Back
Editas Medicine, Inc. Vs. Fortune Brands Innovations, Inc. Industry Stock Comparison
Buy
57
EDIT
Editas Medicine, Inc.
Last Price:
$2.68
Seasonality Move:
5%
Sell
20
FBIN
Fortune Brands Innovations, Inc.
Last Price:
$37.23
Seasonality Move:
3.85%
Buy
57
Editas Medicine, Inc. (EDIT)
is a Buy
Is Editas Medicine, Inc. a Buy, Sell or Hold?
-
The current Editas Medicine, Inc. [EDIT] share price is $2.67. The Score for EDIT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
EDIT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Fortune Brands Innovations, Inc. (FBIN)
is a Sell
Is Fortune Brands Innovations, Inc. a Buy, Sell or Hold?
-
The current Fortune Brands Innovations, Inc. [FBIN] share price is $37.24. The Score for FBIN is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
FBIN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EDIT Stock Price Chart
What is Editas Medicine, Inc.'s stock price today?
-
The Editas Medicine, Inc. share price today is $2.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.
FBIN Stock Price Chart
What is Fortune Brands Innovations, Inc.'s stock price today?
-
The Fortune Brands Innovations, Inc. share price today is $37.24Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBIN is experiencing slight buying pressure.
EDIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 64.05 | Buy |
| Chaikin Money Flow: | 838358 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.14 - 2.54) | Buy |
| Bollinger Bands (100): | (1.98 - 2.52) | Buy |
FBIN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.61 | Sell |
| Relative Strength Index (14 RSI): | 27.15 | Sell |
| Chaikin Money Flow: | 604223 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.25 - 48.13) | Sell |
| Bollinger Bands (100): | (44.39 - 57.45) | Sell |
EDIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Buy |
| 20-day SMA: | 2.41 | Buy |
| 50-day SMA: | 2.14 | Buy |
| 200-day SMA: | 2.59 | Buy |
| 8-day EMA: | 2.42 | Buy |
| 20-day EMA: | 1.93 | Buy |
| 50-day EMA: | 1.14 | Buy |
| 200-day EMA: | 0.36 | Buy |
FBIN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.43 | Sell |
| 20-day SMA: | 41.13 | Sell |
| 50-day SMA: | 50.12 | Sell |
| 200-day SMA: | 52.65 | Sell |
| 8-day EMA: | 38.6 | Sell |
| 20-day EMA: | 41.67 | Sell |
| 50-day EMA: | 46.94 | Sell |
| 200-day EMA: | 52.99 | Sell |
Editas Medicine, Inc. Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.10 per share, an increase this year of $0.88 per share, and an increase next year of $0.19 per share.
Fortune Brands Innovations, Inc. Earnings Growth & FBIN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.37 per share, a decrease this year of $0.27 per share, and an increase next year of $0.50 per share.
Editas Medicine, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fortune Brands Innovations, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||